Your browser doesn't support javascript.
loading
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients.
Maggiolo, Franco; Gulminetti, Roberto; Pagnucco, Layla; Digaetano, Margherita; Cervo, Adriana; Valenti, Daniela; Callegaro, Annapaola; Mussini, Cristina.
Affiliation
  • Maggiolo F; Division of Infectious Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy. franco31556@hotmail.com.
  • Gulminetti R; Division of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Pagnucco L; Division of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Digaetano M; Division of Infectious Diseases, University of Modena, Modena, Italy.
  • Cervo A; Division of Infectious Diseases, University of Modena, Modena, Italy.
  • Valenti D; Division of Infectious Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Callegaro A; Fondazione FROM, Bergamo, Italy.
  • Mussini C; Microbiology and Virology Laboratory, ASST Papa Giovanni XXIII, Bergamo, Italy.
BMC Infect Dis ; 22(1): 782, 2022 Oct 12.
Article in En | MEDLINE | ID: mdl-36224538
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article